Neurology

Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.

Prescribed drugs for diabetes may also reduce the risk of opioid overdoses and alcohol intoxication in patients struggling with addiction according to the results of a new study.

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Traumatic brain injury accounts for 30% of all injury-related deaths in the United States, and is a major cause of death and disability in the country.

A promising treatment strategy for glioblastoma has been unveiled in a significant breakthrough that addresses the urgent need for effective therapeutic options.

Findings reveal the effect of the pandemic on mental health in youth, showing a significant increase in depression and anxiety diagnoses during COVID-19.

Preoperative radiotherapy may significantly enhance survival rates for glioblastoma, a particularly aggressive brain cancer.